- ￥9150
- TargetMol
- 美国
- T38778
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
DB2115 tertahydrochloride
- 库存：
10
- 供应商：
TargetMol
- CAS号：
1366126-19-3
- 规格：
25 mg
Product Introduction
Bioactivity
英文名:DB2115 tertahydrochloride
描述:DB2115 (tertahydrochloride) is a powerful inhibitor of the myeloid master regulator PU.1. With significant potential in cancer research, particularly hematologic cancers like leukemia, as well as other conditions linked to PU.1 dysfunction, DB2115 (tertahydrochloride) offers promising avenues of study.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Wound Watch: An Objective Staging System for Wounds in the Diabetic (db/db) Mouse Model
As in cancer biology, in wound healing there is a need for objective staging systems to decide for the best treatment and predictors of outcome. We developed in the diabetic (db/db) wound healing model, a staging system, the “wound watch
The leptin receptor deficient db/db mouse has served as a rodent model for obesity and type 2 diabetes for more than 40 years. Diabetic features in db/db mice follow an age-dependent progression, with early insulin resistance followed
proteins into ortholog groups based on their sequence similarity. OrthoMCL?DB is a public database that allows users to browse and view ortholog groups that were pre?computed using the OrthoMCL algorithm. Version 4 of this database contained 116,536
技术资料暂无技术资料 索取技术资料
